ATHA (ATHA)

AI-Powered SEC Filing Analysis

Current Report Filed: 2026-01-09

Key Insights

  • Athira Pharma, Inc. has changed its name to LeonaBio, Inc. and updated its ticker symbol to LONA, potentially signaling a strategic shift for the company.
  • The company has entered into an amended change in control and severance agreement with its Chief Financial Officer, Robert Renninger, providing additional protections in the event of his termination.
  • LeonaBio has launched a new corporate website at www.leonabio.com, where investors can find the company's SEC filings, press releases, and other investor relations information.
Filing tone (AI): Neutral
View Original Filing →

Filings on this page are at least 90 days old. In the app, any new ATHA filing is analysed the moment you open it.

Download on theApp Store Get it onGoogle Play

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.